15
3
8
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38182 |
C17 Sphingomyelin (d18:1/17:0)
C17 Sphingomyelin (d18:1/17:0) |
||
C17 Sphingomyelin is a synthetic derivative of sphingomyelin that has been used as an internal standard for the quantification of sphingomyelin. | |||
T37438 |
C17 Globotriaosylceramide (d18:1/17:0)
C17 Globotriaosylceramide (d18:1/17:0) |
||
C17 Globotriaosylceramide is a sphingolipid that has been used as an internal standard for the quantification of globotriaosylceramides in plasma and urine from patients with Fabry disease by GC-MS. | |||
T37437 |
C17 Ceramide (d18:1/17:0)
|
||
C17 Ceramide is a synthetic ceramide that contains a non-natural C17:0 fatty acid acylated to sphingosine. It has been used as a marker of arylsulfatase A and sphingolipid activator B activity in patients undergoing enzyme replacement therapy for the genetic disease metachromatic leukodystrophy. | |||
T38181 |
C17 Lactosylceramide (d18:1/17:0)
|
||
C17 Lactosylceramide is a naturally occurring sphingolipid that has been found in human brain metastases of lung adenocarcinomas but not in healthy brain tissue. | |||
T69430 |
PRMT5-IN-C17
|
||
PRMT5-IN-C17 is a novel potent, selective, and cell active protein arginine methyltransferase 5 (PRMT5) inhibitor. | |||
T29112 |
VPC171
(2-氨基-4-(3-(三氟甲基)苯基)噻吩-3-基)(苯基)甲酮,VPC 171,VPC-171 |
Adenosine Receptor | GPCR/G Protein; Neuroscience |
VPC171 是一种新型腺苷 A1 受体正变构调节剂 (PAM)。 | |||
T35521 |
Aflatoxin G2-13C17
Aflatoxin G2-13C17 |
||
Aflatoxin G2-13C17is intended for use as an internal standard for the quantification of aflatoxin G2by GC- or LC-MS. Aflatoxin G2is a mycotoxin that has been found inAspergillus.1It is lethal to ducklings (LD50= 2.83 mg/kg) but is non-toxic to rats when administered at a dose of 200 mg/kg.2 1.Bennett, J.W., and Klich, M.MycotoxinsClin. Microbiol. Rev.16(3)497-516(2003) 2.Wogan, G.N., Edwards, G.S., and Newberne, P.M.Structure-activity relationships in toxicity and carcinogenicity of aflatoxins a... | |||
T27972 |
MAC173979
MAC-173979,MAC 173979 |
||
MAC173979 inhibits E. coli de novo PABA biosynthesis and growth. | |||
T24599 |
PC170942 Sodium
PC170942 Sodium salt |
||
PC170942 Sodium is a water-soluble bacterial cytokinesis inhibitor that acts by inhibiting FtsZ. | |||
T35519 |
Aflatoxin B2-13C17
Aflatoxin B2-13C17 |
||
Aflatoxin B2-13C17(AFB2-13C17) is intended for use as an internal standard for the quantification of AFB2by GC- or LC-MS. AFB2is a mycotoxin that has been found inA. terricola.1It induces hepatic autophagy and apoptosis in broiler chickens when administered at doses of 0.2, 0.4, and 0.8 mg/kg.2AFB2(0.5 and 1 mg/animal) also induces parenchymal cell hyperplasia in rats.3 1.Moubasher, A.H., el-Kady, I.A., and Shoriet, A.Toxigenic Aspergilli isolated from different sources in EgyptAnn. Nutr. Alimen... | |||
T35762 | MC1742 | ||
MC1742 is an inhibitor of class I histone deacetylases (HDACs; IC50s = 0.1, 0.11, 0.02, and 0.61 μM for HDAC1, -2, -3, and -8, respectively) and class IIb HDACs (IC50s = 7 and 40 nM for HDAC6 and HDAC10, respectively).1 It is selective for class I and class IIb over class IIa HDACs (IC50s = >50 μM for HDAC4, -5, -7, and -9). MC1742 reduces proliferation of HOS, MG-63, RD, A204, SK-ES-1, and A673 sarcoma cancer stem cells (CSCs). It increases levels of acetylated histone H3 and acetylated tubulin... | |||
T35515 |
3-Acetyldeoxy Nivalenol-13C17
3-Acetyldeoxy Nivalenol-13C17 |
||
3-Acetyldeoxy nivalenol-13C17is intended for use as an internal standard for the quantification of 3-acetyldeoxy nivalenol by GC- or LC-MS. 3-Acetyldeoxy nivalenol is a mycotoxin that has been found inF. graminearum.1In vivo, 3-acetyldeoxy nivalenol (40 mg/kg) induces duodenal and splenic cell necrosis, as well as lethality (LD50= 70 mg/kg) in mice.2 1.Jiao, F., Kawakami, A., and Nakajima, T.Effects of different carbon sources on trichothecene production and Tri gene expression by Fusarium grami... | |||
T35520 |
Aflatoxin G1-13C17
Aflatoxin G1-13C17 |
||
Aflatoxin G1-13C17is intended for use as an internal standard for the quantification of aflatoxin G1by GC- or LC-MS. Aflatoxin G1is a mycotoxin that has been found inA. terricola.1In vivo, aflatoxin G1is lethal to ducklings (LD50= 1.18 mg/kg).2It induces hepatocellular carcinoma tumor formation and lethality in rats when administered at doses of 1.4 and 3 mg/animal, respectively. Aflatoxin G1also inhibits liver and kidney succinate dehydrogenase and fumarase, as well as kidney cytochrome oxidase... | |||
T24952 |
ZINC17167211
ZINC-17167211,ZINC 17167211 |
||
ZINC17167211 is a selective peroxisome proliferator-activated receptors-α agonist. | |||
T78764 |
Anticancer agent 136
|
Apoptosis | Apoptosis |
Anticanceragent 136 (compound 22),一种GDM C17-三唑类似物,对HDF表现出3.38 μM的IC50,与Hsp90有3.86 μM的Kd。本化合物功能为细胞凋亡诱导剂。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6S2116 |
Ginkgolic acid C17:1
银杏酸 C17:1,银杏酸C17:1 |
Phosphatase; PTEN | Metabolism; PI3K/Akt/mTOR signaling |
Ginkgolic acid C17:1 是分离自银杏叶中,通过诱导PTEN 和SHP-1酪氨酸磷酸酶抑制组成型和诱导型 STAT3 活化。它具有抗癌活性。 | |||
TN2373 |
(E/Z)-Ginkgolic acid C17:2
Ginkgolic Acid C17:2 |
Dehydrogenase | Metabolism |
(E/Z)-Ginkgolic acid C17:2 (Ginkgolic Acid C17:2) 是一种可从银杏中提取的天然产物,可靶向人二氢乳清酸脱氢酶 (DHODH). | |||
T78473 |
Sphingosine (d17:1)
C17 Sphingosine |
||
Sphingosine (d17:1) (C17 Sphingosine)是一种存在于人类皮肤中的17碳鞘脂,可被鞘氨醇激酶的磷酸化。Sphingosine C-17作为内标可用于进行鞘脂类化合物的光谱分析。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-00685 |
CYTL1 Protein, Mouse, Recombinant (hFc)
CYTL1,C4orf4,Protein C17 |
Mouse | HEK293 Cells |
Cytokine-like protein 1 (Cytl1), also named Protein C17 or C4orf4 is located on human chromosome 4p15-p16 and encodes a polypeptide of 126 amino acid residues that displays characteristics of a secretory protein. Cytl1 is expressed by a sub-population of CD34 human mononuclear cells from bone marrow and cord blood, and by chondrocytes (cartilage-forming cells). | |||
TMPY-00044 |
CYTL1 Protein, Human, Recombinant (mFc)
C4orf4,C17,cytokine-like 1 |
Human | HEK293 Cells |
Cytokine-like protein 1 (CYTL1) is a small widely expressed secreted protein lacking significant primary sequence homology to any other known protein. Cytokine-like 1 (CYTL1) is a novel potential cytokine that was first identified in CD34(+) cells derived from bone marrow and cord blood, and it was also found using our immunogenomics strategy. CYTL1 expression appears to be highest in the hematopoietic system and in chondrocytes; however, maintenance of cartilage in mouse models of arthritis is ... | |||
TMPH-02139 |
CYP17A1 Protein, Human, Recombinant (GST)
Cytochrome P450 17A1,CYPXVII,CYP17A1,CYP17,S17AH,Cytochrome ... |
Human | E. coli |
A cytochrome P450 monooxygenase involved in corticoid and androgen biosynthesis. Catalyzes 17-alpha hydroxylation of C21 steroids, which is common for both pathways. A second oxidative step, required only for androgen synthesis, involves an acyl-carbon cleavage. The 17-alpha hydroxy intermediates, as part of adrenal glucocorticoids biosynthesis pathway, are precursors of cortisol (Probable). Hydroxylates steroid hormones, pregnenolone and progesterone to form 17-alpha hydroxy metabolites, follow... | |||
TMPJ-01456 |
Mucin-17/MUC17 Protein, Human, Recombinant (His)
Mucin-17, MUC-17, MUC17, MUC3, MUC-3 |
Human | HEK293 Cells |
Mucins are key components of the mucosal barrier in the stomach that protects epithelia from carcinogenic effects of chronic inflammation. Analysis of The Cancer Genome Atlas database indicated that mucin17 (MUC17) was more highly expressed in gastric cancer (GC) specimens, with favourable prognosis for patients. And that p38 signalling is a key factor involved in MUC17-mediated inhibition of GC cell proliferation and protection against inflammatory stimulation, MUC17 upregulates the expression ... | |||
TMPH-03400 |
SLC17A6 Protein, Rat, Recombinant (His)
|
Rat | P. pastoris (Yeast) |
Mediates the uptake of glutamate into synaptic vesicles at presynaptic nerve terminals of excitatory neural cells. May also mediate the transport of inorganic phosphate. Involved in the regulation of retinal hyaloid vessel regression during postnatal development. May also play a role in the endocrine glutamatergic system of other tissues such as pineal gland and pancreas. SLC17A6 Protein, Rat, Recombinant (His) is expressed in yeast with C-6xHis tag. The predicted molecular weight is 11.1 kDa an... | |||
TMPY-02572 |
TXNDC17 Protein, Human, Recombinant
thioredoxin domain containing 17,TXNL5,TRP14 |
Human | E. coli |
Thioredoxin-related protein of 14 kDa (TRP14, also called TXNDC17 for thioredoxin domain containing 17, or TXNL5 for thioredoxin-like 5) is an evolutionarily well-conserved member of the thioredoxin (Trx)-fold protein family that lacks activity with classical Trx1 substrates. TXNDC17 is a novel 14-kDa disulfide reductase of the TXN (thioredoxin) family. TXNDC17 is involved in the TNF (tumor necrosis factor) signaling pathway. Moreover, TXNDC17 plays an important role in Taxol resistance via enha... | |||
TMPH-02195 |
TXNDC17 Protein, Human, Recombinant (GST)
|
Human | E. coli |
Disulfide reductase. May participate in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyze dithiol-disulfide exchange reactions. Modulates TNF-alpha signaling and NF-kappa-B activation. Has peroxidase activity and may contribute to the elimination of cellular hydrogen peroxide. | |||
TMPH-01109 |
CCDC174 Protein, Human, Recombinant (His & Myc)
C3orf19,Coiled-coil domain-containing protein 174,CCDC17... |
Human | E. coli |
CCDC174 Protein, Human, Recombinant (His & Myc) is expressed in E. coli. |